Oregon Public Employees Retirement Fund Has $4.29 Million Holdings in Cardinal Health, Inc. $CAH

Oregon Public Employees Retirement Fund lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 32.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,334 shares of the company’s stock after acquiring an additional 6,693 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Cardinal Health were worth $4,290,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. SJS Investment Consulting Inc. increased its holdings in Cardinal Health by 1,363.6% during the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC boosted its position in shares of Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares during the period. Vermillion & White Wealth Management Group LLC grew its holdings in shares of Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after buying an additional 71 shares in the last quarter. Finally, NewSquare Capital LLC grew its holdings in shares of Cardinal Health by 100.0% during the second quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after buying an additional 107 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Price Performance

Shares of CAH stock opened at $201.06 on Friday. The stock has a market cap of $47.77 billion, a P/E ratio of 30.33, a P/E/G ratio of 1.46 and a beta of 0.65. The company has a fifty day moving average price of $204.05 and a two-hundred day moving average price of $173.16. Cardinal Health, Inc. has a one year low of $119.25 and a one year high of $214.93.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same period in the previous year, the business earned $1.88 EPS. Cardinal Health’s revenue for the quarter was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 30.77%.

Analyst Upgrades and Downgrades

Several research firms have commented on CAH. Barclays started coverage on Cardinal Health in a research note on Monday, December 8th. They issued an “overweight” rating and a $243.00 target price on the stock. UBS Group boosted their price objective on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research report on Friday, October 31st. Mizuho increased their target price on shares of Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a report on Monday, November 3rd. Wells Fargo & Company lifted their price target on shares of Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Finally, Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Fourteen analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $212.60.

Read Our Latest Analysis on Cardinal Health

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.